2 results
Approved WMOCompleted
* To compare TKI258 vs. sorafenib with respect to progression-free survival (PFS) determined by central radiology assessment in patients with metastatic renal cell cancer (mRCC) after failure of anti-angiogenic (VEGF-targeted and mTOR inhibitor)…
Approved WMOPending
The primary objective of this study is to assess whether tacrolimus is effective for the treatment of morphea.